See analyst estimates and all valuation multiples for Nutraceuticals & Cosmeceuticals
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $24.5B | 1.5x | 6.6x | |
| $18.3B | 16.5x | 52.0x | |
| $17.3B | 11.2x | 34.2x | |
| $9.4B | 3.0x | 7.4x | |
| $7.3B | 9.7x | 36.3x | |
| $6.5B | 4.2x | 21.3x | |
| $3.7B | 1.9x | 12.4x | |
| $3.7B | 1.7x | 9.8x | |
| $3.6B | n/a | n/a | |
| $3.3B | 2.5x | 9.3x | |
| $2.7B | 9.6x | 23.7x | |
| $2.5B | 8.7x | 17.3x | |
| $1.6B | n/a | n/a | |
| $1.5B | 6.4x | 25.6x | |
| $1.2B | 2.2x | 11.2x | |
| $1.2B | 1.1x | 4.1x | |
| $1.0B | n/a | n/a | |
| $956M | n/a | n/a | |
| $944M | 7.0x | 26.4x | |
| $923M | 6.1x | 17.9x | |
| $889M | 3.6x | 9.3x | |
| $847M | n/a | n/a | |
| $679M | 1.5x | 7.1x | |
| $579M | 4.3x | 15.8x | |
| $548M | 2.2x | 9.3x | |
| $536M | 1.4x | n/a | |
| $476M | 9.8x | 27.7x | |
| $203M | 3.0x | n/a | |
| $156M | 2.4x | 10.9x | |
| $95.0M | n/a | n/a | |
| $25.7M | n/a | n/a | |
| $21.3M | 0.9x | -78.0x | |
| $17.2M | n/a | n/a | |
| $13.1M | 6.0x | -1.2x | |
| $10.1M | n/a | n/a | |
| $3.7M | n/a | n/a | |
| $1.8M | n/a | n/a | |
| -$4.6M | n/a | n/a | |
| -$24.4M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Nutraceuticals & Cosmeceuticals